The pharma ADMET testing market is expected to grow from US$ 6,783.06 million in 2021 to US$ 13,578.62 million by 2028; it is estimated to grow at a CAGR of 10.5% from 2022 to 2028.
The rising number of product approvals and launches drives the market growth. The pharma ADMET testing market comprises major competitive players who adopt various strategies, including product launches, geographic expansion, and technological advancements. A few recent developments in the market are listed below:
- In December 2021, Discovery Life Sciences announced the acquisition of In Vitro ADMET Laboratories (IVAL) to leverage the capabilities of the world's largest hepatocyte inventory and a world-renowned scientific leader. IVAL, Maryland, offers physiologically accurate in vitro experimental systems to increase the effectiveness of toxicology, pharmacology, and drug metabolism testing for the pharmaceutical industry.
- In April 2022, Discovery Life Sciences, a company employing biospecimen and biomarker experts, announced the purchase of the Gentest business unit of Corning Incorporated's Life Sciences division. Gentest will be added to the recently acquired In Vitro ADMET Laboratories, LLC (IVAL) by Discovery Life Sciences. This will make Discovery a prominent provider of in vitro drug trial systems to the pharmaceutical and life sciences industries.
- In October 2021, Genetic Analysis AS (GA), a company specializing in molecular diagnostics, announced a service agreement with Eurofins ADME BIOANALYSES, a Contract Research Organization (CRO) that offers the pharmaceutical industry a range of services in the areas of pharmacokinetics, pharmacodynamics, and drug metabolism.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pharma ADMET Testing Market: Strategic Insights
Market Size Value in US$ 6,783.06 Million in 2021 Market Size Value by US$ 13,578.62 Million by 2028 Growth rate CAGR of 10.5% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pharma ADMET Testing Market: Strategic Insights
| Market Size Value in | US$ 6,783.06 Million in 2021 |
| Market Size Value by | US$ 13,578.62 Million by 2028 |
| Growth rate | CAGR of 10.5% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The active participation of market players in product innovation and development, coupled with an increase in approvals of products, fuels the growth of the pharma ADMET testing market. Also, with the advent of advanced technologies, the market would grow exponentially during the forecast period.
The high cost of ADMET testing studies hinders the growth of the pharma ADMET testing market. As per the Research and Development in the Pharmaceutical Industry, a 2021 report by Congressional Budget Office, the projected cost to develop a new drug can range from less than US$ 1 billion to more than US$ 2 billion, including capital expenses and treatment costs (for patients administered with drugs that don't make it to market). The pharmaceutical industry dedicated US$ 83 billion to R&D expenditures in 2019. These expenditures entailed costs incurred by discovering and testing new drugs, developing incremental innovations such as product extensions, and clinical testing for safety monitoring or marketing purposes. This amount is ~10-times what the industry spent per year in the 1980s. As a result of the unpredictability and high cost of discovering and developing new drugs, only ~12% of medications that undergo clinical trials ultimately receive FDA approval for market launch. Such factors are hindering the growth of the global pharma ADMET testing market.
Regional Overview
Asia Pacific registers the highest CAGR of the pharma ADMET testing market. High demand for toxicology testing products and precision medicines, increasing discovery of drugs, and rising investments in R&D by key market players are among the factors bolstering the growth of the Asia Pacific market.The pharma ADMET testing market in China is expanding due to the country's increasing population suffering from chronic diseases leading to the demand for personalized medicine. Drug discovery in China is booming owing to the support from institutes and organizations promoting in-vitro ADMET testing of the drugs. For instance, Institute for In-Vitro Sciences (IIVS) has worked collaboratively with international governments to help them implement non-animal test methods for the regulation of products and ingredients. In April 2019, IIVS recognized China’s National Medical Products Administration (NMPA) for their acceptance of certain non-animal (alternative) test methods for the regulation of cosmetics.
Moreover, key players operating in the pharma ADMET testing market in China are following organic and inorganic strategies to expand their portfolio and presence across APAC. For instance, in June 2022, WuXi ATU and Wugen Inc. announced a partnership to produce Wugen’s WU-NK-101, a novel immunotherapy that harnesses the power of memory natural killer (NK) cells to treat cancers. Under the partnership, WuXi ATU agreed to provide manufacturing and testing services for WU-NK-101 to enable the delivery of the innovative cell therapy product to cancer patients.
The pharma ADMET testing market in South Korea is growing gradually due to the increased emphasis on drug safety data, new demand for health economics and outcomes research, and shift toward personalized medicine and orphan drug development. South Korea is found to be the most attractive early phase destination based on the availability of global and regional suppliers, patient pool, and the current regulatory scenario of the country. The interest and growth in South Korea in Phase I-IIa studies relative to other areas in Asia, and even relative to the rest of the world, is directly related to the following factors:
- Investment by the South Korean government in developing their biotechnology industry
- Highly educated medical and scientific staff interested in early clinical research
- Access to patients and focus on quality
- Ever-expanding IT infrastructure.
The above factors are propelling the expansion of several CROs across South Korea. Additionally, South Korea announced the launch of a 5-year plan for advancing clinical trials and boosting the country's status as a research destination across the world. In 2019, Novotech company announced a partnership with two major hospitals in South Korea responsible for strengthening Novotech's clinical service capabilities in the country. These factors are expected to fuel the growth of the pharma ADMET testing market in Asia Pacific during the forecast period.
Lucrative Regions for Global Pharma ADMET Testing Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application Insights
Based on application, the global pharma ADMET testing market is segmented into systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others. The systemic toxicity segment is estimated to account for the largest market share during the forecast period. Pharma ADMET testing is performed to identify or spot the toxic effects of drug molecules on organs in the body. If the drug molecule is toxic then it may cause systemic toxicity or organ toxicity. A systemic toxicity affects the entire body or many organs rather than a specific site. ADMET testing finds its application in performing different chemical, pharmacological, and genetic tests that support overall drug discovery activities, including drug trials, drug designs, and other drug interactions. Moreover, there are several drug categories and drug molecules that cause systemic toxicity. Local anesthetic systemic toxicity (LAST) is a life-threatening adverse event that may occur after the administration of local anesthetic drugs through a variety of routes. The increasing use of local anesthetic techniques in various healthcare settings makes contemporary understanding of LAST highly relevant. Additionally, pharma ADMET testing plays a critical role for identifying molecular toxicity and resolving it at the preclinical drug development phase. A study published in Springer Nature in February 2022 entitled “In Silico Models for Predicting Acute Systemic Toxicity” reveals the use of structure-based computational models available and potentially useful in the assessment of acute systemic toxicity.
The hepatotoxicity segment is expected to register the highest CAGR during the forecast period. Hepatotoxicity is the injury or damage to the liver caused by drugs. It is a known and serious adverse drug reaction. Moreover, drug-induced hepatotoxicity is a leading cause of attrition during drug development. In vitro three-dimensional (3D) cell cultures allow better recapitulation of the complex in vivo microenvironment than traditional 2D monolayer models. Thus, the use of such an advanced model to study hepatotoxicity is expected to propel the pharma ADMET testing market growth for this segment during 2021–2028.
Global Pharma ADMET Testing Market, by Application – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Companies operating in the pharma ADMET testing market adopt the product innovation strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the market.
Global Pharma ADMET Testing Market – Segmentation
The pharma ADMET testing market is segmented on the basis of testing type, technology, application, and geography. Based on testing type, the market is segmented into in vivo ADMET testing, in vitro ADMET testing, and in silico ADMET testing. Based on technology, the market is segmented into cell culture, high throughput, molecular imaging, and OMICS technology. Based on application, the global pharma ADMET testing market is segmented into systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Company Profiles
- CMIC Holdings Co., Ltd.
- Charles River Laboratories
- WuXi AppTec
- Promega Corporation
- Merck KGaA
- Agilient Technologies, Inc.
- Biovia (Dassault Systemes)
- Cyprotex Limited
- Bio-Rad Laboratories
- IQVIA Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Testing Type, Technology, and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
ADMET testing expands as for absorption, distribution, metabolism, elimination, and toxicology testing of the drug molecule. These drug tests define the impact of a specific drug or chemical on human tissues. Toxicology testing is an important phenomenon before introducing new medicine to the market. ADMET testing facilitates pharmaceutical manufacturing companies to minimize their drug discovery time, and testing complications, and reduce the cost of drug development.
High rate of late-stage drug failure and the increasing number of product approvals and launches are the most significant factors responsible for the overall market growth.
Based on testing type, the market is segmented into in vivo ADMET testing, in vitro ADMET testing, and in silico ADMET testing. In vivo ADMET testing segment is anticipated to hold a larger share in 2022 and is expected to continue to do so during the forecast period.
CMIC HOLDINGS Co., LTD; Charles River Laboratories; WuXi AppTec; Promega Corporation; MERCK KGaA; Agilent Technologies, Inc.; Biovia (Dassault Systèmes); Cyprotex Limited; Bio-Rad Laboratories, Inc.; and IQVIA Inc. are among the leading companies operating in the global pharma ADMET testing market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Pharma ADMET Testing Market – By Testing Type
1.3.2 Global Pharma ADMET Testing Market – By Technology
1.3.3 Global Pharma ADMET Testing Market – By Application
1.3.4 Global Pharma ADMET Testing Market – By Geography
2. Pharma ADMET Testing Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Pharma ADMET Testing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa – PEST Analysis
4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinion
5. Pharma ADMET Testing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Rate of Late-Stage Drug Failure
5.1.2 Increasing Number of Product Approvals and Launches
5.2 Market Restraints
5.2.1 High Cost of ADME Testing Studies
5.3 Market Opportunities
5.3.1 Automation and Advancements in ADME Testing
5.4 Future Trends
5.4.1 The Advent of High-Throughput Screening
5.5 Impact Analysis
6. Pharma ADMET Testing Market– Global Analysis
6.1 Global Pharma ADMET Testing Market Revenue Forecast and Analysis
6.2 Global Pharma ADME Testing Market, By Geography - Forecast, and Analysis
6.3 Market Positioning of Key Players
6.4 Global Pharma ADME Testing Market – Market Potential Analysis, By Region
6.5 Comparative Company Analysis
6.6 Growth Strategy Analysis
6.7 Performance of Key Players
6.7.1 WuXi AppTec
6.7.2 Charles River Laboratories Inc.
7. Pharma ADMET Testing Market Analysis And Forecasts To 2028 – By Testing Type
7.1 Overview
7.2 Global Pharma ADMET Testing Market, By Testing Type 2022 & 2028 (%)
7.3 In Vivo ADMET Testing
7.3.1 Overview
7.3.2 In Vivo ADMET Testing - Revenue and Forecast to 2028 (US$ Million)
7.4 In Vitro ADMET Testing
7.4.1 Overview
7.4.2 In Vitro ADMET Testing Revenue and Forecast to 2028 (US$ Million)
7.5 In Silico ADMET Testing
7.5.1 Overview
7.5.2 In Silico ADMET Testing Revenue and Forecast to 2028 (US$ Million)
8. Pharma ADMET Testing Market Analysis And Forecasts To 2028 – By Technology
8.1 Overview
8.2 Global Pharma ADMET Testing Market, By Technology 2022 & 2028 (%)
8.3 Cell Culture
8.3.1 Overview
8.3.2 Cell Culture - Market Revenue and Forecast to 2028 (US$ Million)
8.4 High Throughput
8.4.1 Overview
8.4.2 High Throughput - Market Revenue and Forecast to 2028 (US$ Million)
8.5 Molecular Imaging
8.5.1 Overview
8.5.2 Molecular Imaging - Market Revenue and Forecast to 2028 (US$ Million)
8.6 OMICS Technology
8.6.1 Overview
8.6.2 OMICS Technology - Market Revenue and Forecast to 2028 (US$ Million)
9. Global Pharma ADMET Testing Market Analysis– By Application
9.1 Overview
9.2 Global Pharma ADMET Testing Market, By Application 2022 & 2028 (%)
9.3 Systemic Toxicity
9.3.1 Overview
9.3.2 Systemic Toxicity - Market Revenue And Forecasts To 2028 (US$ Million)
9.4 Renal Toxicity
9.4.1 Overview
9.4.2 Renal Toxicity - Market Revenue And Forecasts To 2028 (US$ Million)
9.5 Hepatotoxicity
9.5.1 Overview
9.5.2 Hepatotoxicity - Market Revenue And Forecasts To 2028 (US$ Million)
9.6 Neurotoxicity
9.6.1 Overview
9.6.2 Neurotoxicity - Market Revenue And Forecasts To 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others - Revenue And Forecasts To 2028 (US$ Million)
10. Pharma ADMET Testing Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 North America: Pharma ADMET Testing Market
10.1.1 Overview
10.1.2 North America: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)
10.1.4 North America: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)
10.1.5 North America: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)
10.1.6 North America: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
10.1.6.1 US: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)
10.1.6.1.4 US: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)
10.1.6.1.5 US: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)
10.1.6.2 Canada: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)
10.1.6.2.4 Canada: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)
10.1.6.2.5 Canada: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)
10.1.6.3 Mexico: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)
10.1.6.3.4 Mexico: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)
10.1.6.3.5 Mexico: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)
10.2 Europe: Pharma ADMET Testing Market
10.2.1 Overview
10.2.2 Europe: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
10.2.4 Europe: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6 Europe: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
10.2.6.1 Germany: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Germany: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.2 Germany: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.4 Germany: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2 UK: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 UK: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.2 UK: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 UK: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.4 UK: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3 France: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 France: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.2 France: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 France: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.4 France: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4 Italy: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Italy: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.2 Italy: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.4 Italy: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5 Spain: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Spain: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.2 Spain: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.4 Spain: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6 Rest of Europe: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Rest of Europe: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.2 Rest of Europe: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific Pharma ADMET Testing Market Revenue and Forecasts To 2028
10.3.1 Overview
10.3.2 Asia Pacific Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.3 Asia Pacific: Pharma ADMET Testing Market, by Testing Type, 2019–2028 (US$ Million)
10.3.4 Asia Pacific: Pharma ADMET Testing Market, by Technology, 2019–2028 (US$ Million)
10.3.5 Asia Pacific: Pharma ADMET Testing Market, by Application, 2019–2028 (US$ Million)
10.3.6 Asia Pacific: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)
10.3.6.1 China: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.1.3 China: Pharma ADMET Testing Market, by Testing Type, 2019–2028 (US$ Million)
10.3.6.1.4 China: Pharma ADMET Testing Market, by Technology, 2019–2028 (US$ Million)
10.3.6.1.5 China: Pharma ADMET Testing Market, by Application, 2019–2028 (US$ Million)
10.3.6.2 Japan: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.2.3 Japan: Pharma ADMET Testing Market, by Testing Type, 2019–2028 (US$ Million)
10.3.6.2.4 Japan: Pharma ADMET Testing Market, by Technology, 2019–2028 (US$ Million)
10.3.6.2.5 Japan: Pharma ADMET Testing Market, by Application, 2019–2028 (US$ Million)
10.3.6.3 India: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.3.3 India: Pharma ADMET Testing Market, by Testing Type, 2019–2028 (US$ Million)
10.3.6.3.4 India: Pharma ADMET Testing Market, by Technology, 2019–2028 (US$ Million)
10.3.6.3.5 India: Pharma ADMET Testing Market, by Application, 2019–2028 (US$ Million)
10.3.6.4 South Korea: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.4.3 South Korea: Pharma ADMET Testing Market, by Testing Type, 2019–2028 (US$ Million)
10.3.6.4.4 South Korea: Pharma ADMET Testing Market, by Technology, 2019–2028 (US$ Million)
10.3.6.4.5 South Korea: Pharma ADMET Testing Market, by Application, 2019–2028 (US$ Million)
10.3.6.5 Australia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.5.3 Australia: Pharma ADMET Testing Market, by Testing Type, 2019–2028 (US$ Million)
10.3.6.5.4 Australia: Pharma ADMET Testing Market, by Technology, 2019–2028 (US$ Million)
10.3.6.5.5 Australia: Pharma ADMET Testing Market, by Application, 2019–2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Pharma ADMET Testing Market, by Testing Type, 2019–2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Pharma ADMET Testing Market, by Technology, 2019–2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Pharma ADMET Testing Market, by Application, 2019–2028 (US$ Million)
10.4 Middle East & Africa: Pharma ADMET Testing Market
10.4.1 Overview
10.4.2 Middle East & Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.4.3 Middle East & Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
10.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.4.5 Middle East & Africa: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.4.6 Middle East & Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)
10.4.6.1 UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.1.3 UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
10.4.6.1.4 UAE: Pharma ADMET Testing Market Revenue and Forecasts To 2028, By Technology (US$ Million)
10.4.6.1.5 UAE: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2 Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.2.3 Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
10.4.6.2.4 Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts To 2028, By Technology (US$ Million)
10.4.6.2.5 Saudi Arabia: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3 South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 South Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.3.3 South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
10.4.6.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Technology (US$ Million)
10.4.6.3.5 South Africa: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4 Rest of Middle East and Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East and Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Technology (US$ Million)
10.4.6.4.5 Rest of Middle East and Africa: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.5 South & Central America: Pharma ADMET Testing Market
10.5.1 Overview
10.5.2 South and Central America: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America: Pharma ADMET Testing Market, by Testing Type, 2019–2028 (USD Million)
10.5.4 South and Central America: Pharma ADMET Testing Market, by Technology, 2019–2028 (USD Million)
10.5.5 South and Central America: Pharma ADMET Testing Market, by Application, 2019–2028 (USD Million)
10.5.6 South and Central America: Pharma ADMET Testing Market, by country, 2021 & 2028 (%)
10.5.6.1 Brazil: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.1 Brazil: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.2 Brazil: Pharma ADMET Testing Market, by Testing Type, 2019–2028 (USD Million)
10.5.6.1.3 Brazil: Pharma ADMET Testing Market, by Technology, 2019–2028 (USD Million)
10.5.6.1.4 Brazil: Pharma ADMET Testing Market, by Application, 2019–2028 (USD Million)
10.5.6.2 Argentina: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.1 Argentina: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.2 Argentina: Pharma ADMET Testing Market, by Testing Type, 2019–2028 (USD Million)
10.5.6.2.3 Argentina: Pharma ADMET Testing Market, by Technology, 2019–2028 (USD Million)
10.5.6.2.4 Argentina: Pharma ADMET Testing Market, by Application, 2019–2028 (USD Million)
10.5.6.3 Rest of South and Central America: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.1 Rest of South and Central America: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.2 Rest of South and Central America: Pharma ADMET Testing Market, by Testing Type, 2019–2028 (USD Million)
10.5.6.3.3 Rest of South and Central America: Pharma ADMET Testing Market, by Technology, 2019–2028 (USD Million)
10.5.6.3.4 Rest of South and Central America: Pharma ADMET Testing Market, by Application, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Pharma ADMET Testing Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Pharma ADMET Testing Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 CMIC HOLDINGS Co., LTD
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Charles River Laboratories
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 WuXi AppTec
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Promega Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sigma-Aldrich (MERCK KGaA)
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Agilent Technologies, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Biovia (Dassault Systèmes)
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Cyprotex Limited
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Bio-Rad Laboratories, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 IQVIA Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 3. North America Pharma ADMET Testing Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 4. US Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 6. US Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Germany: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 19. UK: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. UK: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 22. France: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. France: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 24. France: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 35. Asia Pacific: Pharma ADMET Testing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 37. China: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. China: Pharma ADMET Testing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 39. China: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 40. Japan: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan: Pharma ADMET Testing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 43. India: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 44. India: Pharma ADMET Testing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 45. India: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 46. South Korea: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 47. South Korea: Pharma ADMET Testing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 49. Australia: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia: Pharma ADMET Testing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia Pacific: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific: Pharma ADMET Testing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 55. Middle East & Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
Table 56. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 57. Middle East & Africa: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 58. UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
Table 59. UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 60. UAE: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 61. Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
Table 62. Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 63. Saudi Arabia: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 64. South Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
Table 65. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 66. South Africa: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Middle East & Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
Table 68. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 69. Rest of Middle East and Africa: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 70. South and Central America: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)
Table 71. South and Central America: Pharma ADMET Testing Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 72. South and Central America: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 73. Brazil: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)
Table 74. Brazil: Pharma ADMET Testing Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 75. Brazil: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 76. Argentina: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)
Table 77. Argentina: Pharma ADMET Testing Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 78. Argentina: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 79. Rest of South and Central America: Pharma ADMET Testing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 80. Rest of South and Central America: Pharma ADMET Testing Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 81. Rest of South and Central America: Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 82. Organic Developments Done by Companies
Table 83. Inorganic Developments Done by Companies
Table 84. Glossary of Terms
LIST OF FIGURES
Figure 1. Pharma ADMET Testing Market Segmentation
Figure 2. Pharma ADMET Testing Market, By Region
Figure 3. Global Pharma ADMET Testing Market Overview
Figure 4. In vivo ADMET Testing Segment Held Largest Share of Testing Type Segment in Pharma ADMET Testing Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Pharma ADMET Testing Market, by Geography (US$ Million)
Figure 7. Global Pharma ADMET Testing Market - Leading Country Markets (US$ Million)
Figure 8. Global Pharma ADMET Testing Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Pharma ADMET Testing Market Impact Analysis of Driver and Restraints
Figure 15. Global Pharma ADME Testing Market– Revenue Forecast and Analysis – 2022 - 2028
Figure 16. Global Pharma ADME Testing Market – By Geography Forecast and Analysis – 2022 - 2028
Figure 17. Market Positioning of Key Players in Pharma ADME Testing Market
Figure 18. Global Pharma ADME Testing Market – Market Potential Analysis, By Region
Figure 19. Global Pharma ADME Testing Market – Comparative Company Analysis
Figure 20. Global Pharma ADME Testing Market – Growth Strategy Analysis
Figure 21. Global Pharma ADMET Testing Market, by Testing Type 2022 & 2028 (%)
Figure 22. In Vivo ADMET Testing - Revenue and Forecasts to 2028 (US$ Million)
Figure 23. In Vitro ADMET Testing Revenue and Forecasts to 2028 (US$ Million)
Figure 24. In Silico ADMET Testing Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Global Pharma ADMET Testing Market, by Technology 2022 & 2028 (%)
Figure 26. Cell Culture - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. High Throughput - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Molecular Imaging - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. OMICS Technology - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Global Pharma ADMET Testing Market, by Application 2022 & 2028 (%)
Figure 31. Systemic Toxicity - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 32. Renal Toxicity - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 33. Hepatotoxicity - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 34. Neurotoxicity - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 35. Others - Revenue And Forecasts To 2028 (US$ Million)
Figure 36. North America: Pharma ADMET Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 37. North America Pharma ADMET Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
Figure 39. US: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Canada: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Mexico: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Europe: Pharma ADMET Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 43. Europe: Pharma ADMET Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 44. Europe: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
Figure 45. Germany: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. UK: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. France: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Italy: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Spain: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Rest of Europe: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Asia Pacific Pharma ADMET Testing Market Overview, by Country (2022)
Figure 52. Asia Pacific: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 53. Asia Pacific: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)
Figure 54. China: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 55. Japan: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 56. India: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. South Korea: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 58. Australia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 59. Rest of Asia Pacific: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. Middle East & Africa Pharma ADMET Testing Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 61. Middle East & Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 62. Middle East & Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)
Figure 63. UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 64. Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 65. South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 66. Rest of Middle East and Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 67. South and Central America: Pharma ADMET Testing Market, by Key Country – Revenue (2022) (US$' Million)
Figure 68. South and Central America Pharma ADMET Testing Market Revenue and Forecast to 2028 (USD Million)
Figure 69. South and Central America: Pharma ADMET Testing Market, by country, 2021 & 2028 (%)
Figure 70. Brazil: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (USD Million)
Figure 71. Argentina: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (USD Million)
Figure 72. Rest of South and Central America: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (USD Million)
Figure 73. Impact of COVID-19 Pandemic in North American Country Markets
Figure 74. Impact of COVID-19 Pandemic in European Country Markets
Figure 75. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 76. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 77. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 78. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Pharma ADMET Testing Market
- CMIC HOLDINGS Co., LTD
- Charles River Laboratories
- Wuxi AppTec
- Promega Corporation
- MERCK KGaA
- Agilent Technologies, Inc.
- Biovia (Dassault Systèmes)
- Cyprotex Limited
- Bio-Rad Laboratories, Inc.
- IQVIA Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Pharma ADMET Testing Market
Jul 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jul 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jul 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jul 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jul 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)